Designed to stabilize and fuse the SI joint

iFuse Implant SizesSI-BONE, Inc. has developed a minimally invasive surgical (MIS), innovative, patented, sacroiliac implant system for sacroiliac (SI) joint fusion. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/ous/risks

The iFuse Implant System® consists of titanium implants and associated surgical instruments. Typically, patients receive three triangular-shaped titanium implants. Available implant lengths range from 30mm to 70mm in 5mm increments. These implants are delivered to the sacroiliac (SI) joint using a cannulated delivery system designed to protect soft tissue. The surgery is performed through a 2-3cm incision.

Potential iFuse benefits

  • Minimally invasive surgical (MIS) approach is less invasive than traditional fusion surgery without extensive soft tissue stripping
  • Triangular implant profile minimizes rotation
  • An interference fit between the implant and the adjacent osseous walls
  • Porous surface promotes bony ongrowth and ingrowth1
  • TPS technology used for decades in other medical applications such as orthopedics and dentistry
  • Designed specifically to stabilize and fuse the heavily loaded SI joint
  • Rigid titanium construction and implant geometry provide immediate stabilization 
  • More than thirty published, peer-reviewed articles demonstrate safety and effectiveness of the iFuse procedure.2

With the iFuse Implant System, there is no need for:

  • Preparation of the joint prior to implant
  • BMP or autologous bone graft
  • Additional pedicle screws and rods
  • Hollow modular anchorage screws
  • Cannulated compression screws
  • Threaded cages within the joint
  • Fracture fixation screws

Possible benefits versus traditional surgical SI joint fixation3

  • Smaller incision size
  • Less soft tissue stripping
  • Minimal tendon irritation

Possible benefits of a minimally invasive surgical procedure3

  • MIS procedure with small incision
  • Drill, broach, insert iFuse and close
  • Cannulated delivery system
  • Minimal blood loss

 

The iFuse Implant System is CE marked as a medical device in the EEA and Switzerland and is intended sacroiliac joint fusion. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/ous/risks

  1. MacBarb, et al., “Fortifying the Bone-Implant Interface Part II: An In Vivo Evaluation of 3D-Printed and TPS-Coated Triangular Implants,” Int J Spine Surg, 2017; 11.
  2. Polly, D.W. et al., Neurosurgery. 2015.— Dr. Polly is an investigator on a clinical research study sponsored by SI-BONE. He has no financial interest in SI-BONE. Research was funded by SI-BONE, Inc. A list of additional published studies is available at www.si-bone.com/ous/results
  3. Arnold Graham Smith* et al. Open versus minimally invasive sacroiliac joint fusion: a multi-center comparison. Annals of Surgical Innovation and Research 2013, 7:14. *Paid consultant of SI-BONE Inc.

Learn